Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: The RAINBOW analysis

Sergio Bracarda, R. Iacovelli, L. Boni, M. Rizzo, L. Derosa, M. Rossi, L. Galli, G. Procopio, M. Sisani, F. Longo, M. Santoni, F. Morelli, G. Di Lorenzo, A. Altavilla, C. Porta, A. Camerini, B. Escudier, Angelo Martignetti, Riccardo Ricotta, Donatello GasparroRoberto Sabbatini, Giovanni Luca Ceresoli, Alessandra Mosca, Daniele Santini, Claudia Caserta, Luigi Cavanna, Francesco Massari, Teodoro Sava, Corrado Boni, Elena Verzoni, Giacomo Cartenì, Alketa Hamzaj

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: The RAINBOW analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences